137 related articles for article (PubMed ID: 12843791)
1. TNFalpha-based isolated perfusion for limb-threatening soft tissue sarcomas: state of the art and future trends.
Rossi CR; Mocellin S; Pilati P; Foletto M; Nitti D; Lise M
J Immunother; 2003; 26(4):291-300. PubMed ID: 12843791
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermic isolated limb perfusion in locally advanced limb soft tissue sarcoma: A 24-year single-centre experience.
Rastrelli M; Campana LG; Valpione S; Tropea S; Zanon A; Rossi CR
Int J Hyperthermia; 2016; 32(2):165-72. PubMed ID: 26608883
[TBL] [Abstract][Full Text] [Related]
3. Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
Di Filippo F; Giacomini P; Rossi CR; Santinami M; Garinei R; Anzà M; Deraco M; Botti C; Perri P; Cavaliere F; Di Angelo P; Sofra C; Sperduti I; Pasqualoni R; Di Filippo S; Corrias F; Armenti A; Ferraresi V
In Vivo; 2009; 23(2):363-7. PubMed ID: 19414428
[TBL] [Abstract][Full Text] [Related]
4. Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerations.
Issakov J; Merimsky O; Gutman M; Kollender Y; Lev-Chelouche D; Abu-Abid S; Lifschitz-Mercer B; Inbar M; Klausner JM; Meller I
Ann Surg Oncol; 2000 Mar; 7(2):155-9. PubMed ID: 10761796
[TBL] [Abstract][Full Text] [Related]
5. Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas.
Hegazy MA; Kotb SZ; Sakr H; El Dosoky E; Amer T; Hegazi RA; Farouk O
Ann Surg Oncol; 2007 Feb; 14(2):568-76. PubMed ID: 17094027
[TBL] [Abstract][Full Text] [Related]
6. Hyperthermic isolated limb perfusion in the management of extremity sarcoma.
Hoekstra HJ; van Ginkel RJ
Curr Opin Oncol; 2003 Jul; 15(4):300-3. PubMed ID: 12874508
[TBL] [Abstract][Full Text] [Related]
7. Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase I study.
Di Filippo F; Rossi CR; Vaglini M; Azzarelli A; Anzà M; Santinami M; Lise M; Cavaliere F; Giannarelli D; Quagliuolo V; Vecchiato A; Deraco M; Garinei R; Foletto M; Botti C; Cavaliere R
J Immunother; 1999 Sep; 22(5):407-14. PubMed ID: 10546156
[TBL] [Abstract][Full Text] [Related]
8. Phase II study on neoadjuvant hyperthermic-antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomas.
Rossi CR; Vecchiato A; Foletto M; Nitti D; Ninfo V; Fornasiero A; Sotti G; Tregnaghi A; Melanotte P; Lise M
Cancer; 1994 Apr; 73(8):2140-6. PubMed ID: 8156518
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermic isolated limb perfusion with tumour necrosis factor-alpha and melphalan as palliative limb-saving treatment in patients with locally advanced soft-tissue sarcomas of the extremities with regional or distant metastases. Is it worthwhile?
Olieman AF; van Ginkel RJ; Molenaar WM; Schraffordt Koops H; Hoekstra HJ
Arch Orthop Trauma Surg; 1998; 118(1-2):70-4. PubMed ID: 9833110
[TBL] [Abstract][Full Text] [Related]
10. [Results of isolated hyperthermic extremity perfusion in soft tissue sarcomas within the scope of a multimodality treatment concept].
Schwarzbach M; Lehnert T; Willeke F; Hinz U; Herfarth C
Chirurg; 1996 Dec; 67(12):1237-43. PubMed ID: 9081786
[TBL] [Abstract][Full Text] [Related]
11. Hyperthermic isolated perfusion with low-dose tumor necrosis factor alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcomas.
Rossi CR; Mocellin S; Pilati P; Foletto M; Campana L; Quintieri L; De Salvo GL; Lise M
Ann Surg Oncol; 2005 May; 12(5):398-405. PubMed ID: 15915374
[TBL] [Abstract][Full Text] [Related]
12. Isolated limb perfusion for soft tissue sarcoma: Current practices and future directions. A survey of experts and a review of literature.
Martin-Tellez KS; van Houdt WJ; van Coevorden F; Colombo C; Fiore M
Cancer Treat Rev; 2020 Aug; 88():102058. PubMed ID: 32619864
[TBL] [Abstract][Full Text] [Related]
13. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
Andreou D; Werner M; Pink D; Traub F; Schuler MK; Gosheger G; Jobke B; Reichardt P; Tunn PU
Int J Hyperthermia; 2016; 32(2):159-64. PubMed ID: 26670477
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermic isolated perfusion with low-dose TNFalpha and doxorubicin in patients with locally advanced soft tissue limb sarcomas.
Rossi CR; Foletto M; Mocellin S; Pilati P; Quintieri L; De Salvo GL; Nitti D; Lise M
J Chemother; 2004 Nov; 16 Suppl 5():58-61. PubMed ID: 15675481
[TBL] [Abstract][Full Text] [Related]
15. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.
Eggermont AM; Schraffordt Koops H; Klausner JM; Kroon BB; Schlag PM; Liénard D; van Geel AN; Hoekstra HJ; Meller I; Nieweg OE; Kettelhack C; Ben-Ari G; Pector JC; Lejeune FJ
Ann Surg; 1996 Dec; 224(6):756-64; discussion 764-5. PubMed ID: 8968230
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcoma.
Di Filippo F; Garinei R; Anzà M; Cavaliere F; Giannarelli D; Cagol PP; Rossi CR; Santinami M; Deraco M; Botti C; Perri P; Di Filippo S; Piarulli L; Bruno P
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):81-7. PubMed ID: 16767912
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant Hypertermic Isolated Limb Perfusion in Treatment of Undifferentiated Spindle Cell Sarcoma of Lower Limb with Achieved Complete Pathologic Response.
Vočka M; Špaček M; Matějovský Z; Trnka J; Hodková G; Skibová D; Zogala D; Lindner J; Petruželka L
Klin Onkol; 2019; 32(3):211-213. PubMed ID: 31216854
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas.
Deroose JP; Eggermont AM; van Geel AN; Burger JW; den Bakker MA; de Wilt JH; Verhoef C
J Clin Oncol; 2011 Oct; 29(30):4036-44. PubMed ID: 21931039
[TBL] [Abstract][Full Text] [Related]
19. Multifocal soft tissue sarcoma: limb salvage following hyperthermic isolated limb perfusion with high-dose tumor necrosis factor and melphalan.
Lev-Chelouche D; Abu-Abeid S; Kollander Y; Meller I; Isakov J; Merimsky O; Klausner JM; Gutman M
J Surg Oncol; 1999 Mar; 70(3):185-9. PubMed ID: 10102350
[TBL] [Abstract][Full Text] [Related]
20. Current uses of isolated limb perfusion in the clinic and a model system for new strategies.
Eggermont AM; de Wilt JH; ten Hagen TL
Lancet Oncol; 2003 Jul; 4(7):429-37. PubMed ID: 12850194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
